Long survival in an elderly patient with acute myeloid leukaemia after treatment with harringtonine.
A remission was achieved in a 73-year-old woman with acute myeloid leukaemia after treatment with harringtonine. The remission lasted 3 1/2 years and she remained alive at the four-year follow-up.
D000368:Aged; D000470:Alkaloids / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D004906:Erythrocyte Count; D005260:Female; D005500:Follow-Up Studies; D006248:Harringtonines / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D007958:Leukocyte Count; D010976:Platelet Count
D000470:Alkaloids; D006248:Harringtonines